Investing.com - Sanara Medtech (NASDAQ: SMTI) reported first quarter EPS of $-0.03, $0.10 better than the analyst estimate of $-0.13. Revenue for the quarter came in at $17.7M versus the consensus estimate of $16.5M.
Sanara Medtech's stock price closed at $36.25. It is down -11.86% in the last 3 months and down -5.55% in the last 12 months.
Sanara Medtech saw positive EPS revisions and negative EPS revisions in the last 90 days. See Sanara Medtech's stock price’s past reactions to earnings here.
According to InvestingPro, Sanara Medtech's Financial Health score is "good performance".
Check out Sanara Medtech's recent earnings performance, and Sanara Medtech's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar